Condition: Sugammadex · Sponsor: University of California, Davis
This is a single site, prospective, non-blinded, non-randomized, before/after study. This study is designed to evaluate the impact of monitoring and reversal guidelines for neuromuscular blocking drugs on the post-operative outcomes for patients undergoing laparoscopic gastric bypass surgery.
This description comes directly from the study's public registry record.
Ana P Arias, BS · 916-703-5456 · apaarias@ucdavis.edu
Julio J Arana Pineda, BA · 916-734-4074 · jjaranapineda@ucdavis.edu
Always discuss trial participation with your own doctor first.
| UC Davis Medical Center | Sacramento, California, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05886218